TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma


Ahmed Idbaih, et al.
ASCO 2017, June 2017 – Download the abstract
Abstract

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00 - Fax. : + 33 (0) 3 88 27 91 11

 

© 2018 Transgene - All rights reserved
Mentions légales - Crédits